Sientra, Inc. (NASDAQ:SIEN) Q4 2022 Earnings Call Transcript

Page 5 of 5

So I think it’s getting a lot of momentum. We’ve had two launch webinars with several hundred customers logging in to learn about this technology. I’ve been fortunate to be present in many cases the last couple of weeks and the consistent feedback has been very positive. We’re also seeing standard use in other areas beyond the breast. There is — recently at the Northeastern Society of Plastic Surgeons presentation on the use of Viality for facial feminization fat grafting. We’re also seeing in the body, in the buttock, , scar treatment, radiation burns as a study that we’re running. So we’re starting to see how the expanded use will bring additional benefits beyond the breast use, which is where we have been focused on for the early experience in the launch.

Anthony Vendetti: And then just maybe just a follow up and then on the margins. This is higher margin than your breast products at this point, right?

Ron Menezes: It will be in Q4. As I said, right now, we’re at kind of our entry level volumes and production. And what we’re going to do, just on the technical side is all the prototyping work we’re doing, the early work, we’re going to push that through the P&L and not park it on the balance sheet. So we’ll take any of that early experience type production learnings and just push it through first part of the year here. Q4, expected to be like a tissue expander plus to where it’s a 70 point plus gross margin product.

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to management for any closing remarks. Please go ahead.

Ron Menezes: Well, I just want to say thank you everyone. This is, as like I said before, pivotal year for Sientra, we have the ability this year to lever our new platform, Sientra platform with our new products and with the same customers who have been calling the last 10 years. So thank you again for joining us. We look forward for a great 2023.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Sientra Inc. (NASDAQ:SIEN)

Page 5 of 5